Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
788K
-
Shares change
-
+51.6K
-
Total reported value, excl. options
-
$136M
-
Value change
-
+$9.13M
-
Put/Call ratio
-
0.26
-
Number of buys
-
35
-
Number of sells
-
-35
-
Price
-
$175.44
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q1 2021
117 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q1 2021.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 788K shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (119K shares), MORGAN STANLEY (63.9K shares), ROYAL BANK OF CANADA (52K shares), Kestra Advisory Services, LLC (42.1K shares), UBS Group AG (40.7K shares), MURPHY CAPITAL MANAGEMENT INC (33.9K shares), BANK OF AMERICA CORP /DE/ (33.4K shares), MOGY JOEL R INVESTMENT COUNSEL INC (27.8K shares), LPL Financial LLC (21K shares), and STIFEL FINANCIAL CORP (20.4K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.